Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Prognosis in patients with hepatocellular carcinoma correlates to mutations of p53 and/or hMSH2 genes.

Yano M, Hamatani K, Eguchi H, Hirai Y, MacPhee DG, Sugino K, Dohi K, Itamoto T, Asahara T.

Eur J Cancer. 2007 Apr;43(6):1092-100. Epub 2007 Mar 12.

PMID:
17350822
2.

Close correlation between a p53 or hMSH2 gene mutation in the tumor and survival of hepatocellular carcinoma patients.

Yano M, Asahara T, Dohi K, Mizuno T, Iwamoto KS, Seyama T.

Int J Oncol. 1999 Mar;14(3):447-51.

PMID:
10024676
3.

The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan.

Hayashi H, Sugio K, Matsumata T, Adachi E, Takenaka K, Sugimachi K.

Hepatology. 1995 Dec;22(6):1702-7.

PMID:
7489977
4.

p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation.

Honda K, Sbisà E, Tullo A, Papeo PA, Saccone C, Poole S, Pignatelli M, Mitry RR, Ding S, Isla A, Davies A, Habib NA.

Br J Cancer. 1998 Mar;77(5):776-82.

5.

The significance of p53 mutations as an indicator of the biological behavior of recurrent hepatocellular carcinomas.

Sugo H, Takamori S, Kojima K, Beppu T, Futagawa S.

Surg Today. 1999;29(9):849-55.

PMID:
10489124
6.

High levels of p53 protein expression do not correlate with p53 mutations in hepatocellular carcinoma.

Anzola M, Saiz A, Cuevas N, Lopez-Martinez M, Martinez de Pancorbo MA, Burgos JJ.

J Viral Hepat. 2004 Nov;11(6):502-10.

PMID:
15500550
7.

Close correlation of p53 mutation to microvascular invasion in hepatocellular carcinoma.

Park NH, Chung YH, Youn KH, Song BC, Yang SH, Kim JA, Lee HC, Yu E, Lee YS, Lee SG, Kim KW, Suh DJ.

J Clin Gastroenterol. 2001 Nov-Dec;33(5):397-401.

PMID:
11606857
8.
9.

Clinical value of alterations in p73 gene, related to p53 at 1p36, in human hepatocellular carcinoma.

Aoki T, Miyamoto A, Marubashi S, Nagano H, Umeshita K, Fujiwara Y, Dono K, Nakamori S, Sakon M, Monden M.

Int J Oncol. 2004 Feb;24(2):441-6.

PMID:
14719122
11.

Molecular prediction of early recurrence after resection of hepatocellular carcinoma.

Yoshioka S, Takemasa I, Nagano H, Kittaka N, Noda T, Wada H, Kobayashi S, Marubashi S, Takeda Y, Umeshita K, Dono K, Matsubara K, Monden M.

Eur J Cancer. 2009 Mar;45(5):881-9. doi: 10.1016/j.ejca.2008.12.019. Epub 2009 Jan 23.

PMID:
19167881
12.

Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.

Pang JZ, Qin LX, Ren N, Hei ZY, Ye QH, Jia WD, Sun BS, Lin GL, Liu DY, Liu YK, Tang ZY.

Clin Cancer Res. 2007 Dec 15;13(24):7363-9.

13.

p53 abnormalities in hepatocellular carcinoma from United States patients: analysis of all 11 exons.

Kazachkov Y, Khaoustov V, Yoffe B, Solomon H, Klintmalm GB, Tabor E.

Carcinogenesis. 1996 Oct;17(10):2207-12.

14.

Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma.

Ko E, Kim Y, Kim SJ, Joh JW, Song S, Park CK, Park J, Kim DH.

Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2260-7. doi: 10.1158/1055-9965.EPI-08-0236. Epub 2008 Aug 22.

15.

p53 mutation in HCV-genotype-4 associated hepatocellular carcinoma in Egyptian patients.

Zekri AR, Bahnassy AA, Madbouly MS, Asaad NY, El-Shehaby AM, Alam El Din HM.

J Egypt Natl Canc Inst. 2006 Mar;18(1):17-29.

16.

Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.

Su H, Zhao J, Xiong Y, Xu T, Zhou F, Yuan Y, Zhang Y, Zhuang SM.

Mutat Res. 2008 May 10;641(1-2):27-35. doi: 10.1016/j.mrfmmm.2008.02.005. Epub 2008 Feb 14.

PMID:
18358501
17.

Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma.

Yuan RH, Jeng YM, Hu RH, Lai PL, Lee PH, Cheng CC, Hsu HC.

J Gastrointest Surg. 2011 Feb;15(2):321-9. doi: 10.1007/s11605-010-1373-x.

PMID:
21061181
18.

Genetic analysis of the LKB1/STK11 gene in hepatocellular carcinomas.

Kim CJ, Cho YG, Park JY, Kim TY, Lee JH, Kim HS, Lee JW, Song YH, Nam SW, Lee SH, Yoo NJ, Lee JY, Park WS.

Eur J Cancer. 2004 Jan;40(1):136-41.

PMID:
14687797
19.

Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation.

Tanaka S, Toh Y, Adachi E, Matsumata T, Mori R, Sugimachi K.

Cancer Res. 1993 Jun 15;53(12):2884-7.

20.

Clonality analysis for multicentric origin and intrahepatic metastasis in recurrent and primary hepatocellular carcinoma.

Li Q, Wang J, Juzi JT, Sun Y, Zheng H, Cui Y, Li H, Hao X.

J Gastrointest Surg. 2008 Sep;12(9):1540-7. doi: 10.1007/s11605-008-0591-y. Epub 2008 Jul 16.

PMID:
18629593
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk